Tanzania United Republic of

in page functions
[French]
Tanzania United Republic of
Total population (2018) 58,636,330
Birth cohort (2018) 2,184,450
Surviving Infants (surviving to 1 year per year, 2018) 2,116,880
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 35/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 49/1000
World Bank Index, IDA (2015) 3.67
Gross Nation Income (per capita US$, 2015) 920
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 194

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Tanzania United Republic of

Type of support

Approvals

2001-2022 (US$)
(22 Jun 2018)

Commitments

2001-2022 (US$)
(22 Jun 2018)

Disbursements

2000-2018 (US$)
(22 Jun 2018)

% Disbursed

(22 Jun 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $404,245,919 $529,634,909 $400,631,271
Cash Support (CASHSUPP) $205,484 $205,484 $205,484 100%
Cold Chain Equipment Optimisation Platform (CCEOP) $8,878,132 N/A
Health system strengthening (HSS 1) $17,497,223 $17,497,223 $11,657,462 67%
HPV (NVS) $7,558,000 $20,230,500 $6,053,600 80%
HPV Demo (NVS) $703,101 $703,101 $703,101 100%
HPV MAC (NVS) $30,208,500 N/A
HPV MAC - Op costs (OPC) $2,224,858 N/A
Immunisation services support (ISS) $11,413,380 $11,413,380 $11,413,380 100%
Injection Safety Devices (NVS) $1,447,200 $3,276,700 $1,728,460 119%
Injection safety support (INS) $1,016,452 $1,016,452 $1,016,452 100%
IPV (NVS) $4,114,833 $4,114,833 $2,081,133 51%
Measles (NVS) $2,058,670 $2,773,170 $1,368,248 66%
Measles-Rubella (NVS) $14,899,227 $14,899,227 $14,899,227 100%
MR - Operational costs (OPC) $11,544,485 $11,544,485 $11,544,485 100%
Penta (NVS) $91,455,602 $98,919,602 $90,663,519 99%
Pneumo (NVS) $154,120,114 $199,424,614 $161,991,193 105%
Rotavirus (NVS) $51,230,745 $67,323,245 $50,324,124 98%
Tetra DTP-HepB (NVS) $24,774,552 $24,774,552 $24,774,552 100%
Vaccine Introduction Grant (VIG) $10,206,851 $10,206,851 $10,206,851 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Tanzania United Republic of DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 97%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2009) 88.20%
Household survey: DTP3 coverage for female (2009) 87.80%
Household survey: Last DTP3 survey (2009) 88%
% districts achieving > 80% DTP3 coverage (2017) 91%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2016) 90%

Breakdown of support

Non-vaccine support Vaccine support
11% 89%
$46,044,114 $354,587,157

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Tanzania United Republic of

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

12 November 2015

Gavi default item

Measles vaccination has saved an estimated 17.1 million lives since 2000

New data released by the World Health Organization (WHO) for the Measles & Rubella Initiative, estimates that 17.1 million lives have been saved since 2000, largely due to increased vaccination coverage against this highly contagious viral disease.

18 August 2015

Cameroon cholera campaign

People in Cameroon to be protected against cholera with Gavi-supported vaccine

More than 110,000 doses of oral cholera vaccine will protect people in the northern region.

close icon

modal window here